Arch Therapeutics, Inc.
ARTHQ
$0.0001
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.26M | -8.43M | -7.86M | -6.98M | -6.41M |
| Total Depreciation and Amortization | 2.40K | 2.30K | 2.10K | 2.10K | 2.20K |
| Total Amortization of Deferred Charges | 2.68M | 2.90M | 2.95M | 2.31M | 1.78M |
| Total Other Non-Cash Items | 4.03M | 102.90K | -986.80K | -908.70K | -842.30K |
| Change in Net Operating Assets | 1.84M | 1.74M | 2.31M | 2.20M | 1.66M |
| Cash from Operations | -3.70M | -3.69M | -3.59M | -3.37M | -3.82M |
| Capital Expenditure | -4.50K | -4.50K | -4.50K | -4.50K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.50K | -4.50K | -4.50K | -4.50K | -- |
| Total Debt Issued | 1.79M | 1.83M | 1.93M | 995.00K | 4.20M |
| Total Debt Repaid | -345.80K | -346.40K | -348.40K | -350.40K | -354.30K |
| Issuance of Common Stock | 2.21M | 2.21M | 2.21M | 2.21M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.65M | 3.69M | 3.79M | 2.85M | 3.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.50K | -3.10K | 195.20K | -524.20K | 31.50K |